Refine by
Bioreactor System Services
10 services found
Manufactured by:CELONIC Group based inBasel, SWITZERLAND
Celonic utilizes advanced instrumentation, multi-scale bioreactors and leading-edge technologies for process development, production and purification of mRNA candidates. ...
Manufactured by:Accellta based inHaifa, ISRAEL
Process development services for culturing stem cells and or their derivatives in feeder-free, xeno-free, serum-free 3D non-adherent conditions in spinners and bioreactors. Process development services for differentiation of stem cells to the desired cell type in feeder-free, xeno-free, serum-free 3D non-adherent conditions in spinners or bioreactors. Protocols for culturing and differentiation ...
Manufactured by:Forge Biologics, Inc. based inGrove City, OHIO (USA)
We offer a robust platform approach wholly built for AAV production. That means you have access to a leadership team with 165+ years of industry experience, 200,000+ sq. ft. cGMP facility, proprietary technologies optimized for safety, and a company that shares our clients’ missions of advancing potential treatments for those who need them the most. ...
Manufactured by:AventaCell BioMedical Corp based inAtlanta, GEORGIA (US) (USA)
Mesenchymal stem cells (MSC) are multipotent cells with regenerative, multidifferentiation, and immunomodulatory capacities. Expanding MSC for clinical purposes usually requires large cell dose, which demanding efficient cultivation ...
Manufactured by:mAbxience based inMadrid, SPAIN
Independent CDMO platform with complete range of analytical and development processes to provide clients with end-to-end ...
Manufactured by:Nuvonis based inVienna, AUSTRIA
The generation of high titer vaccines with acceptable purity is a challenging task, both regarding upstream and downstream steps. Upstream development uses well established technologies such as bioreactors (e.g., single use) or high-cell density systems based on microcarrier technology. An integral part of process development is the fine funing between cell ...
Manufactured by:ProBioGen AG based inBerlin, GERMANY
You want to overcome the historic way to manufacture viral vaccines on embryonated chicken eggs or on finite cultures of primary avian and mammalian origin. You want to avoid challenges in supply and scalability, variable performance, and increasing costs for source material and extensive safety testing. You are looking for a modern serum-free process avoiding traditional, technically demanding ...
by:Biovian Oy based inTurku, FINLAND
The state-of-the-art production facility allows for flexible viral vector production scenarios. The cleanroom class C (EU GMP) and biosafety level 2 facility is designed for the manufacturing of GMP-grade viral vectors. The space design follows a modular ballroom concept and unidirectional process flow. The equipment are mobile, allowing for easy reconfiguring, and the operations are performed ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as it develops its product candidates for major markets including the United States, Europe, Japan and ...
by:NOVO Engineering based inVista, CALIFORNIA (USA)
Device Types: Ambulatory Insulin Pumps; Patch Pumps; Smart Pens & Pen Caps; CGM Systems; Mobile Apps; Automated Insulin Delivery (AID) ...